• ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Media
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspective
Weekly Newscast
dvm360 LIVE!™
Insights
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Client Handouts
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Coverage
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2022 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2022 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

New York Racehorse veterinarian pleads guilty in federal doping case

May 13, 2022
dvm360 Staff

Louis Grasso, DVM, and Racehorse Trainer Richard Banca pleaded guilty to distributing and administering prohibited performance-enhancing drugs.

Damian Williams, the United States Attorney for the Southern District of New York, announced earlier this week that veterinarian Louis Grasso and trainer Richard Banca plead guilty to their participation in the distribution of adulterated and misbranded drugs with the intent to defraud and mislead. According to a United States Department of Justice release, the charges were filed in connection with United States v. Grasso et al., 20 Cr. 163 (OKC).1

“Grasso and Banca represent the corruption and greed of those in the racehorse industry looking to win at any cost. In peddling illegal drugs and selling prescriptions to corrupt trainers, Louis Grasso abdicated his responsibilities as a medical professional to ensure the safety and health of the racehorses he ‘treated,’” said Williams.1

“By injecting horses with unnecessary and, at times, unknown drugs, Grasso risked the lives and welfare of the animals under his care, all in service of helping corrupt racehorse trainers like Banca line their pockets through fraud. These latest convictions demonstrate the commitment of this Office and of our partners at the FBI to hold accountable individuals seeking to profit from animal abuse and deceit,” he continued.

According to court documents1, the charges in this case came from an investigation of “widespread schemes by racehorse trainers, veterinarians, PED distributors, and others to manufacture, distribute, and receive adulterated and misbranded PEDs and to secretly administer those PEDs to racehorses competing at all levels of professional horseracing.”

These schemes involve participants evading PED prohibits and deceiving regulators and horse racing officials to improve race performance and receive prize money at racetracks throughout the United States. These schemes put the racehorse’s health and well-being at risk.

Grasso allegedly accepted payment in exchange for him to write prescriptions for the performance-enhancing drugs and creating, distributing, and administering custom-made performance-enhancing drugs that were adulterated and misbranded substances. The goal of these drugs was solely to improve the performance of the horses.

Grasso helped the corrupted trainers involved collect over $47 million in illegally acquired purse winnings. This case is currently being handled by the Office’s Money Laundering and Transnational Criminal Enterprises Unit. Assistant United States Attorneys Sarah Mortazavi and Anden Chow are overseeing the prosecution.1

Reference

New York racehorse veterinarian and standardbred trainer plead guilty in federal doping case. Justice.gov. Published May 11, 2022. Accessed May 13, 2022. https://www.justice.gov/usao-sdny/pr/new-york-racehorse-veterinarian-and-standardbred-trainer-plead-guilty-federal-doping

Related Content:

Equine
Kemin Equine  hosts EquiSUMMIT
Kemin Equine hosts EquiSUMMIT
Meet the Fetch Faculty: Rachel Allbaugh, DVM, MS, DACVO
Meet the Fetch Faculty: Rachel Allbaugh, DVM, MS, DACVO
Equine Disease Communication Center awarded federal grant to increase biosecurity awareness, mitigate spread of infectious disease
Equine Disease Communication Center awarded federal grant to increase biosecurity awareness, mitigate spread of infectious disease

Latest News

Animal pain management: where have we been and where are we going?

ACANA hairball control food receives FDA approval

Wellness Pet Company debuts new brand of natural dog treats

Louisville Zoo welcomes baby zebra

View More Latest News